ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIOS BioPlus Acquisition Corporation

10.795
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
BioPlus Acquisition Corporation NASDAQ:BIOS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.795 10.79 11.28 0 01:00:00

BioScrip to Host 2015 Fourth Quarter and Year-End Results Call

10/03/2016 12:46am

GlobeNewswire Inc.


BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more BioPlus Acquisition Charts.

BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 fourth quarter and year-end financial results on Wednesday, March 2, 2016, after the close of the U.S. financial markets.

Richard M. Smith, President and Chief Executive Officer, and Jeffrey M. Kreger, Chief Financial Officer and Treasurer, will conduct a conference call as follows:

  DateThursday, March 3, 2016
Time8:30 a.m. EST
Toll free (U.S.)888-372-9592
International918-559-5628
Webcast (live and replay)www.bioscrip.com
  

A replay of the conference call will be available for one week after the call's completion by dialing 855-859-2056 (US) or 404-537-3406 (International) and entering conference call ID number 55165908. An audio webcast and archive will also be available for 30 days under the "Investor Relations" section of the BioScrip website at www.bioscrip.com.

About BioScrip, Inc.BioScrip, Inc. is a leading national provider of infusion and home healthcare management solutions. BioScrip partners with healthcare providers, including physicians, hospital systems, skilled nursing facilities, and with healthcare payors to provide patients better access to high quality, efficient post-acute care services. BioScrip operates with a commitment to bring infusion therapy services into the home or alternate-site settings. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Contact:
Lisa Wilson 
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

1 Year BioPlus Acquisition Chart

1 Year BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

Your Recent History

Delayed Upgrade Clock